Literature DB >> 4899881

The enzymatic termination of polydeoxynucleotides by 2',3'-dideoxyadenosine triphosphate.

L Toji, S S Cohen.   

Abstract

The nucleoside 2',3'-dideoxyadenosine is lethal to E. coli and blocks DNA synthesis irreversibly. The hypothesis that a derived dideoxynucleoside triphosphate is incorporated terminally into the cellular DNA has been tested in an in vitro system. The triphosphate of dideoxyadenosine was synthesized and shown to inhibit the in vitro synthesis of DNA by purified E. coli DNA polymerase. The kinetics of inhibition of nucleotide incorporation and pyrophosphate exchange were studied. Early in synthesis the dideoxynucleotide is a competitive inhibitor of the enzyme. Subsequently, synthesis is almost completely arrested.Radioactive dideoxyadenosine triphosphate was prepared. The compound was shown to be incorporated enzymatically into dAT copolymer to the extent of about one molecule per molecule of template. It is released from such templates by DNA polymerase at less than 1 per cent of the rate of release of other natural nucleotides. The label is released by snake venom phosphodiesterase far more rapidly than total nucleotides. This nucleoside triphosphate has thus been shown to be a competitive inhibitor of DNA polymerase and a terminator of polydeoxynucleotide chains.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4899881      PMCID: PMC223533          DOI: 10.1073/pnas.63.3.871

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  8 in total

1.  NUCLEOTIDE SEQUENCE ANALYSIS OF POLYRIBONUCLEOTIDES BY MEANS OF PERIODATE OXIDATION FOLLOWED BY CLEAVAGE WITH AN AMINE.

Authors:  H C NEU; L A HEPPEL
Journal:  J Biol Chem       Date:  1964-09       Impact factor: 5.157

2.  Enzymatic synthesis of deoxyribonucleic acid. II. General properties of the reaction.

Authors:  M J BESSMAN; I R LEHMAN; E S SIMMS; A KORNBERG
Journal:  J Biol Chem       Date:  1958-07       Impact factor: 5.157

3.  Enzymatic synthesis of deoxyribonucleic acid. I. Preparation of substrates and partial purification of an enzyme from Escherichia coli.

Authors:  I R LEHMAN; M J BESSMAN; E S SIMMS; A KORNBERG
Journal:  J Biol Chem       Date:  1958-07       Impact factor: 5.157

4.  Active center of DNA polymerase.

Authors:  A Kornberg
Journal:  Science       Date:  1969-03-28       Impact factor: 47.728

5.  Enzymatic breakage and joining of deoxyribonucleic acid. V. End group labeling and analysis of deoxyribonucleic acid containing single straned breaks.

Authors:  B Weiss; T R Live; C C Richardson
Journal:  J Biol Chem       Date:  1968-09-10       Impact factor: 5.157

6.  Purine nucleosides. XIV. Unsaturated furanosyl adenine nucleosides prepared via base-catalyzed elimination reactions of 2'-deoxyadenosine derivatives.

Authors:  J R McCarthy; M J Robins; L B Townsend; R K Robins
Journal:  J Am Chem Soc       Date:  1966-04-05       Impact factor: 15.419

7.  Purine nucleosides. XII. The preparation of 2',3'-dideoxyadenosine, 2',5'-dideoxyadenosine, and 2',3',5'-trideoxyadenosine from 2'-deoxyadenosine.

Authors:  M J Robins; J R McCarthy; R K Robins
Journal:  Biochemistry       Date:  1966-01       Impact factor: 3.162

8.  Polymer synthesis in killed bacteria: lethality of 2',3'-dideoxyadenosine.

Authors:  A M Doering; M Jansen; S S Cohen
Journal:  J Bacteriol       Date:  1966-09       Impact factor: 3.490

  8 in total
  11 in total

Review 1.  Therapeutic Approaches for Zika Virus Infection of the Nervous System.

Authors:  Rachel P M Abrams; Jamie Solis; Avindra Nath
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Induction of the SOS response in Escherichia coli by azidothymidine and dideoxynucleosides.

Authors:  S W Mamber; K W Brookshire; S Forenza
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

3.  Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome.

Authors:  T W North; G L North; N C Pedersen
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

Review 4.  Pharmacokinetic individualisation of zidovudine therapy. Current state of pharmacokinetic-pharmacodynamic relationships.

Authors:  R M Hoetelmans; D M Burger; P L Meenhorst; J H Beijnen
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

5.  Antibacterial activity of 2',3'-dideoxyadenosine in vivo and in vitro.

Authors:  G Beskid; B Eskin; R Cleeland; J Siebelist; A Cappetta; A D Hill; R H Geiger
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

6.  Broad spectrum antiretroviral activity of 2',3'-dideoxynucleosides.

Authors:  J E Dahlberg; H Mitsuya; S B Blam; S Broder; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

7.  Termination of deoxyribonucleic acid in Escherichia coli by 2',3'-dideoxyadenosine.

Authors:  L Toji; S S Cohen
Journal:  J Bacteriol       Date:  1970-08       Impact factor: 3.490

8.  Isolation and characterization of an Escherichia coli mutant deficient in dTMP kinase activity.

Authors:  T D Daws; J A Fuchs
Journal:  J Bacteriol       Date:  1984-02       Impact factor: 3.490

9.  Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro.

Authors:  H Mitsuya; R F Jarrett; M Matsukura; F Di Marzo Veronese; A L DeVico; M G Sarngadharan; D G Johns; M S Reitz; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

Review 10.  Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants.

Authors:  Jennifer Jao; Elaine J Abrams
Journal:  Pediatr Infect Dis J       Date:  2014-07       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.